A A A

Click below to share this page

Feed icon

Latest Human Wellbeing News

Whole body anterior amyloid scans of a patient with systemic amyloidosis, showing abundant amyloid in the liver before treatment and the almost complete absence of amyloid after a single dose of the new anti-SAP antibody.

Improving treatment for systemic amyloidosis

Published: Jul 16, 2015 11:57:29 AM

Scientist examines samples under a microscope

UCL to coordinate £16m project to crack difficult disease areas

Published: Jul 15, 2015 10:25:45 AM

Professor Nick Fox and Dr Jonathan Schott

Landmark 69-year study to provide window into dementia

Published: Jul 14, 2015 10:05:31 AM


ANNOUNCEMENTS



Archive of Latest Human Wellbeing News

<< 2014 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2016 >>

Improving treatment for systemic amyloidosis

Publication date:

Whole body anterior amyloid scans of a patient with systemic amyloidosis, showing abundant amyloid in the liver before treatment and the almost complete absence of amyloid after a single dose of the new anti-SAP antibody.

A potential new approach to treat systemic amyloidosis, invented at UCL and being developed by GlaxoSmithKline (GSK), marks the start of a successful and innovative academic-industry collaboration.

UCL to coordinate £16m project to crack difficult disease areas

Publication date:

Scientist examines samples under a microscope

UCL has successfully coordinated a £16 million bid to work with the Medical Research Council (MRC), GSK and four other universities to improve scientists’ understanding of inflammatory and fibrotic diseases that present a serious burden to patients.

Landmark 69-year study to provide window into dementia

Publication date:

Professor Nick Fox and Dr Jonathan Schott

A landmark study that has been following a group of people since their birth in the same week in March 1946 is now turning its focus to the risk factors and early signs of dementia.

Commonly prescribed drugs affect decisions to harm oneself and others

Publication date:

Pills

Healthy people given the serotonin-enhancing antidepressant citalopram were willing to pay almost twice as much to prevent harm to themselves or others than those given placebo drugs in a moral decision-making experiment at UCL.

<< 2014 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2016 >>